Fortitude Family Office’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.09K Sell
60
-132
-69% -$15.2K ﹤0.01% 923
2026
Q1
$22.9K Buy
192
+31
+19% +$4.07K 0.01% 398
2025
Q4
$21.9K Sell
161
-3
-2% -$431 0.01% 384
2025
Q3
$24.2K Buy
164
+2
+1% +$277 0.01% 357
2025
Q2
$21K Buy
162
+32
+25% +$3.88K 0.01% 371
2025
Q1
$15.5K Hold
130
0.01% 447
2024
Q4
$15.1K Hold
130
0.01% 522
2024
Q3
$17.6K Hold
130
0.01% 443
2024
Q2
$17.6K Buy
+130
New +$17.7K 0.01% 321

Other funds holding XYL

Fortitude Family Office's XYL Position: Q2 2026 in Review

Fortitude Family Office reduced its Xylem (XYL) stake by 69% in Q2 2026, selling an estimated $15.2K and leaving 60 shares worth $7.09K. The position accounts for ﹤0.01% of the portfolio, ranked #923.

Fortitude Family Office first reported a position in XYL in Q2 2024 and has held it in 9 quarters since. The position peaked at $24.2K in Q3 2025. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Fortitude Family Office held 60 shares of Xylem worth $7.09K as of Q2 2026.
  • Fortitude Family Office sold 132 Xylem shares in Q2 2026, an estimated $15.2K.
  • Xylem made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #923 holding.
  • Fortitude Family Office first reported a position in Xylem in Q2 2024 and has held it in 9 quarters since.
  • Fortitude Family Office's Xylem position peaked at $24.2K in Q3 2025.
  • 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.